期刊文献+

中医辨证治疗脑梗死的45例临床观察 被引量:4

Clinical Observation of 45 Cases of Cerebral Infarction Treated with Syndrome differentiation in Chinese medicine
下载PDF
导出
摘要 目的观察中西医结合治疗脑梗死的临床疗效及治疗前后血液流变学指标变化。方法将87例脑梗死患者随机分为两组。对照组42例采用西医常规治疗方法,治疗组45例在对照组治疗基础上加服中药并用中医辨证治疗,疗程均为4周。观察两组临床疗效以及治疗前后血液流变学指标变化。结果两组疗效比较中,治疗组总有效率86.67%,对照组总有效率57.14%,两组比较,差异有统计学意义(P<0.01),治疗组疗效优于对照组。治疗组治疗后全血低切黏度、全血高切黏度及血液黏度与本组治疗前及对照组治疗后比较,差异均有统计学意义(P<0.05或P<0.01);两组治疗前后血小板聚集率比较差异均有统计学意义(P<0.05或P<0.01),但两组治疗后比较,差异无统计学意义(P>0.05)。结论在常规治疗基础上加用中医辨证治疗对于急性脑梗死恢复期的疗效更为显具,明显优于西医常规治疗。 Objective To observe the clinical efficacy of integrated Chinese and western medicine on cerebral infarction and the changes in hemorheological indicators before and after treatment.Methods 87 cases of cerebral infarction were randomly divided into two groups.In control group(42 cases),the conventional western medicine was adopted.In treatment group(45 cases),on the basis of the treatment as control group,Chinese herbal medicine was combined according to syndrome differentiation of Chinese medicine.The duration of treatment was 4 weeks.The clinical efficacy and the changes in hemorheological indicators before and after treatment were observed in two groups.Results In efficacy comparison of two group,the total effective rate was 86.67% in treatment group and was 57.14% in control group,indicating significant statistical difference in comparison(P0.01).The efficacy in treatment group was superior to control group.The whole blood viscosity of low shear rate,whole blood viscosity of high shear rate and blood viscosity after treatment were different significantly as compared with those before treatment in treatment group as well as those after treatment in control group in statistics(P0.05 or P0.01).The platelet aggregation before treatment was different significantly in statistics between two groups(P0.05 or P0.01),but after treatment,there was no significant statistical difference between two groups(P0.05).Conclusion On the basis of conventional treatment,the treatment according to syndrome differentiation in Chinese medicine achieves better efficacy on acute cerebral infarction in recovery stage,which is superior apparently to conventional treatment with western medicine.
作者 张艳
出处 《世界中西医结合杂志》 2011年第2期145-147,共3页 World Journal of Integrated Traditional and Western Medicine
关键词 恢复期 脑梗死 中药疗法 Recovery Stage Cerebral Infraction Therapy of Chinese Medicine
  • 相关文献

参考文献5

二级参考文献5

共引文献33135

同被引文献36

  • 1楼小亮,詹细平,李晓萍,徐江霞,范华,龚淑琪,谭建萍,刘海江,徐剑君.血浆溶血磷脂酸水平与缺血性脑卒中预后关系的研究[J].中华危重病急救医学,2008,20(11). 被引量:10
  • 2狄晴,葛剑青,陈道文,徐肖,陈惠玲,过燕萍,李继民,石静萍,张颖冬,李作汉.依达拉奉治疗急性脑梗死的临床观察[J].临床神经病学杂志,2004,17(3):184-186. 被引量:303
  • 3Guo Jian-jun,Xu En, Lin Qing-yuan, et al. Effect of cilostazol oncerebral arteries in secondary prevention of ischemic stroke [J]. Neu-rosci Bull,2009,25(6):383-390.
  • 4Hennekens CH. Aspirin in the treatment and prevention of cardio- vas-cular disease current perspectives and future directions [J]. Curt Ath-emscler Rep, 2007, 9(5): 409-416.
  • 5张藉藉,齐杰玉.急性脑梗死患者血浆纤维蛋白原和D-二聚体水平的变化[J].中国动踩硬化杂志,2009,17(4):321-322.
  • 6Baigent C,Blackwell L,Collins R,et al.Aspiriin in the primary andsecondary prevention of vascular diseasexollaborative meta-analysisof individual participant data from randomised trials [J] .Lancet,2009,373(9678):1849-1860.
  • 7Shinohara Y,Katayama Y,Uchiyama S,et al.Cilostazol for preventionof secondary stroke (csps2):an aspirin-controlled,double-blind,ran-domised non-inferiority trial[J],Lancet Neurol,2010,9(10):959-968.
  • 8Maasland L,van Oostenbrugge RJ,Franke CF,et al.Patienta enrolled inlarge randomized clinical trials of antiplatelet treatment for preven-tion after transient ischemic attack or ischemic strocke ate not repre-sentative of patients in clinical practice:the Netherlands Stroke Survey[J].Stroke,2009,(8):2662-2668.
  • 9应爱娟.步长脑心通胶囊对急性脑梗死患者全血粘度及纤維蛋白原变化的影响[J].当代医学(学术版),2007,12(131):104-106.
  • 10骆磊,章培林.益气活血中药治疗进展性脑梗死的早期疗效观察[J].中国中药杂志,2009,34(10):1295-1296. 被引量:7

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部